inositol-3,4,5,6-tetrakisphosphate has been researched along with epidermal growth factor in 1 studies
Studies (inositol-3,4,5,6-tetrakisphosphate) | Trials (inositol-3,4,5,6-tetrakisphosphate) | Recent Studies (post-2010) (inositol-3,4,5,6-tetrakisphosphate) | Studies (epidermal growth factor) | Trials (epidermal growth factor) | Recent Studies (post-2010) (epidermal growth factor) |
---|---|---|---|---|---|
68 | 0 | 8 | 24,155 | 217 | 4,699 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eckmann, L; Fierer, J; Jiang, T; Kagnoff, MF; Ptasznik, A; Rudolf, MT; Schultz, C; Shears, SB; Traynor-Kaplan, AE; Tsien, R; Wolfson, N | 1 |
1 other study(ies) available for inositol-3,4,5,6-tetrakisphosphate and epidermal growth factor
Article | Year |
---|---|
D-myo-Inositol 1,4,5,6-tetrakisphosphate produced in human intestinal epithelial cells in response to Salmonella invasion inhibits phosphoinositide 3-kinase signaling pathways.
Topics: Epidermal Growth Factor; Humans; Inositol Phosphates; Intestinal Mucosa; Phosphatidylinositol 3-Kinases; Salmonella Infections; Signal Transduction | 1997 |